ZEAL — Zealand Pharma A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK20.34bn
- DKK5.63bn
- DKK9.21bn
Annual cashflow statement for Zealand Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,018 | -1,202 | -704 | -1,079 | 6,455 |
| Depreciation | |||||
| Non-Cash Items | -22.8 | 151 | 177 | -106 | 780 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -211 | -9.51 | 76 | 229 | -731 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,212 | -942 | -426 | -931 | 6,532 |
| Capital Expenditures | -22.1 | -11.7 | -23.7 | -13.1 | -69.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.01 | 293 | -1,070 | -7,320 | -2,179 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.1 | 281 | -1,094 | -7,333 | -2,249 |
| Financing Cash Flow Items | -46.9 | -47.4 | -71.9 | -237 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,333 | 588 | 907 | 8,288 | -378 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 169 | -59.9 | -620 | 31 | 3,851 |